Evidence map›Paper›PMID 42281835›Full record

ArticleChemical science2026

Quinoid-controlled bond-length alternation enables high-mobility non-fused π-conjugated polymers.

Tsubasa Mikie, Keitaro Iguchi, Ryosuke Kamimura, Kenta Tanaka, Hiroyuki Ishii, Itaru Osaka

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tsubasa MikieGraduate School of Advanced Science and Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima Hiroshima 739-8527 Japan mikie@hiroshima-u.ac.jp iosaka@hiroshima-u.ac.jp.ORCID https://orcid.org/0000-0003-0532-8905
Keitaro IguchiGraduate School of Advanced Science and Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima Hiroshima 739-8527 Japan mikie@hiroshima-u.ac.jp iosaka@hiroshima-u.ac.jp.
Ryosuke KamimuraSchool of Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima Hiroshima 739-8527 Japan.
Kenta TanakaGraduate School of Advanced Science and Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima Hiroshima 739-8527 Japan mikie@hiroshima-u.ac.jp iosaka@hiroshima-u.ac.jp.
Hiroyuki IshiiInstitute of Pure and Applied Sciences, University of Tsukuba Tsukuba Ibaraki 305-8573 Japan.ORCID https://orcid.org/0000-0003-0644-1424
Itaru OsakaGraduate School of Advanced Science and Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima Hiroshima 739-8527 Japan mikie@hiroshima-u.ac.jp iosaka@hiroshima-u.ac.jp.ORCID https://orcid.org/0000-0002-9879-2098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achieving high charge-carrier mobility in π-conjugated polymers typically requires the incorporation of fused-ring frameworks that ensure backbone planarity and rigidity (intrachain transport) and π-π stacking (interchain transport). Here we show that high mobility can instead arise from efficient intrachain transport even in fully non-fused polymer backbones through precise control of quinoid resonance and bond-length alternation (BLA). A series of S-Pechmann (SP)-based polymers having alkoxy side chains were designed in which the quinoidal character was systematically tuned by varying the length of the oligothiophene co-units. Increasing quinoidal character markedly suppresses BLA along the polymer backbone, leading to pronounced π-electron delocalization and reduced carrier effective masses as low as ∼0.05

Identifiers

PMID42281835
PMCPMC13250828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.